Omega Therapeutics Inc (OMGA)
1.96
-0.21
(-9.68%)
USD |
NASDAQ |
May 10, 16:00
1.955
0.00 (0.00%)
After-Hours: 20:00
Omega Therapeutics Total Liabilities (Quarterly): 142.33M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 142.33M |
| December 31, 2023 | 146.35M |
| September 30, 2023 | 141.76M |
| June 30, 2023 | 133.10M |
| March 31, 2023 | 33.32M |
| December 31, 2022 | 40.03M |
| September 30, 2022 | 36.41M |
| Date | Value |
|---|---|
| June 30, 2022 | 35.66M |
| March 31, 2022 | 35.95M |
| December 31, 2021 | 32.70M |
| September 30, 2021 | 22.93M |
| June 30, 2021 | 222.53M |
| March 31, 2021 | 221.95M |
| December 31, 2020 | 92.71M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
22.93M
Minimum
Sep 2021
222.53M
Maximum
Jun 2021
95.55M
Average
66.37M
Median
Total Liabilities (Quarterly) Benchmarks
| Fate Therapeutics Inc | 137.80M |
| Ocular Therapeutix Inc | 130.96M |
| AnaptysBio Inc | 364.29M |
| Amneal Pharmaceuticals Inc | 3.473B |
| Stoke Therapeutics Inc | 64.84M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 183.68M |
| Shareholders Equity (Quarterly) | 41.35M |
| Debt to Equity Ratio | 0.4328 |
| Current Ratio | 2.872 |
| Net Debt Paydown Yield | 0.20% |